Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,036,000 | 1,898,000 | 1,295,000 | 1,176,000 | 1,099,000 |
| Marketable Securities | 7,579,000 | 7,565,000 | 7,721,000 | 6,633,000 | 5,764,000 |
| Receivables | 4,798,000 | 5,679,000 | 5,435,000 | 5,773,000 | 5,489,000 |
| Inventories | 2,485,000 | 2,842,000 | 2,926,000 | 2,889,000 | 2,702,000 |
| Other current assets | 1,896,000 | 241,000 | 285,000 | 138,000 | 140,000 |
| TOTAL | $19,212,000 | $19,999,000 | $19,598,000 | $18,698,000 | $17,187,000 |
| Non-Current Assets | |||||
| PPE Net | 9,783,000 | 10,166,000 | 9,818,000 | 9,601,000 | 9,425,000 |
| Investments And Advances | 5,724,000 | 4,258,000 | 3,218,000 | 2,373,000 | 2,529,000 |
| Intangibles | 1,689,000 | 1,764,000 | 1,776,000 | 1,797,000 | 1,791,000 |
| Other Non-Current Assets | 2,745,000 | 2,619,000 | 2,531,000 | 2,677,000 | 2,578,000 |
| TOTAL | $19,941,000 | $18,807,000 | $17,343,000 | $16,448,000 | $16,323,000 |
| Total Assets | $39,153,000 | $38,806,000 | $36,941,000 | $35,146,000 | $33,510,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,263,000 | 6,362,000 | 4,638,000 | 3,963,000 | 4,289,000 |
| Accounts payable and accrued liabilities | 1,411,000 | 1,632,000 | 1,542,000 | 1,418,000 | 1,719,000 |
| Accrued Expenses | 1,026,000 | 1,010,000 | 965,000 | 928,000 | 982,000 |
| Other current liabilities | 2,866,000 | 3,115,000 | 3,113,000 | 3,508,000 | 3,445,000 |
| TOTAL | $13,729,000 | $13,039,000 | $11,984,000 | $10,874,000 | $11,981,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,609,000 | 2,087,000 | 2,367,000 | 1,888,000 | 1,123,000 |
| Other Non-Current Liabilities | 4,124,000 | 4,351,000 | 4,139,000 | 4,034,000 | 3,950,000 |
| TOTAL | $7,131,000 | $6,871,000 | $7,141,000 | $6,524,000 | $5,453,000 |
| Total Liabilities | $20,860,000 | $19,910,000 | $19,125,000 | $17,398,000 | $17,434,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,265,231 | 6,286,722 | 6,312,711 | 6,312,851 | N/A |
| Common Shares | 340,000 | 339,000 | 338,000 | 338,000 | 337,000 |
| Retained earnings | 24,430,000 | 23,967,000 | 21,899,000 | 21,444,000 | 19,599,000 |
| Other shareholders' equity | -4,399,000 | -4,368,000 | -4,369,000 | -4,196,000 | -4,897,000 |
| TOTAL | $18,293,000 | $18,896,000 | $17,816,000 | $17,748,000 | $16,076,000 |
| Total Liabilities And Equity | $39,153,000 | $38,806,000 | $36,941,000 | $35,146,000 | $33,510,000 |